Vittorio Fregoni

Sondalo, 23035, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study.

Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study.

Journal: Journal of clinical medicine

Published: January 24, 2024

Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes.

Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes.

Journal: Research and practice in thrombosis and haemostasis

Published: December 28, 2022

Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register.

Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: January 11, 2022

Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study.

Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study.

Journal: Future science OA

Published: November 25, 2020

Covid19: Could other alternatives have been possible?

Covid19: Could other alternatives have been possible?

Journal: Journal of global antimicrobial resistance

Published: May 04, 2020

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 21, 2018

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma.

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma.

Journal: Journal of neuro-oncology

Published: November 08, 2018

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 21, 2018

Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.

Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.

Journal: Cancer chemotherapy and pharmacology

Published: January 29, 2015

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 17, 2012

No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer.

No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: November 21, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026